| Literature DB >> 21959696 |
E M Van Schie-Van der Weert1, E M M Van Lieshout, M R De Vries, M Van der Elst, T Schepers.
Abstract
INTRODUCTION: Treatment of ankle fractures is often based on fracture type and surgeon's individual judgment. Literature concerning the treatment options and outcome are dated and frequently contradicting. The aim of this study was to determine the clinical and functional outcome after AO-Weber B-type ankle fractures in operatively and conservatively treated patients and to determine which factors influenced outcome. PATIENTS AND METHODS: A retrospective cohort study in patients with a AO-Weber B-type ankle fracture. Patient, fracture and treatment characteristics were recorded. Clinical and functional outcome was measured using the Olerud-Molander Ankle Score (OMAS), the American Orthopaedic Foot and Ankle Society ankle-hindfoot score (AOFAS) and a Visual Analog Score (VAS) for overall satisfaction (range 0-10).Entities:
Mesh:
Year: 2011 PMID: 21959696 PMCID: PMC3261401 DOI: 10.1007/s00402-011-1397-z
Source DB: PubMed Journal: Arch Orthop Trauma Surg ISSN: 0936-8051 Impact factor: 3.067
Literature overview of studies comparing operative versus conservative treatment of ankle fractures
| Study design | No. of patients | ORIF ( | Cons ( | Average age (years) | Mean follow-up (months) | Clinical Outcome favors ORIF? − no; + yes; = equal | |
|---|---|---|---|---|---|---|---|
| Dietrich et al. [ | P | 57 | 23 | 34 | 49 | 17 | − |
| Makwana et al. [ | RCT | 43 | 22 | 21 | >55 | 27 | + |
| Anand 1993 [ | R | 80 | 39 | 41 | >60 | 28 (O), 25.5 (C) | + |
| Rowley et al. [ | RCT | 42 | 20 | 22 | 16–70 | 5 | = |
| Bauer et al. [ | RCT | 92 | 43 | 49 | 50 | 84 | =/early + |
| Philips et al. [ | RCT | 71 | 45 | 26 | 41 | 42 | + |
| Beauchamp et al. [ | R | 126 | 71 | 55 | >50 | 24 | = |
| Tunturi et al. [ | R | 239 | 124 | 115 | 46 | 36 | = (Depending on radiological result) |
| Yde 1980 [ | R | 69 | 34 | 35 | 15–49 | 36–120 | = (in SER2) |
| Yde 1980 [ | R | 89 | 60 | 29 | 15–75 | 36–120 | + (in SER4) |
| Eventov 1978 [ | R | 200 | 101 | 99 | 16–87 | 48 | − |
| Malka 1969 [ | R | 50 | 25 | 25 | N.A. | 19.4 | =/+ |
| Wilson 1966 [ | R | 55 | 28 | 27 | 45.3 | 97 | = |
P Prospective, R retrospective, RCT randomized controlled trial, SER# supination exorotation fracture, O ORIF, C conservative treatment, N.A. not available
Baseline characteristics
| Total | Conservative | Operative |
| |
|---|---|---|---|---|
|
| 185 | 82 | 103 | |
| Malesa | 72 (38.9) | 33 (40.2) | 39 (37.9) | 0.763c |
| Age (years)b | 50.6 (37.9–58.7) | 50.1 (35.7–58.2) | 50.7 (41.1–60.5) | 0.258d |
| BMI (kg/m2)b | 25.5 (23.2–28.7) | 24.8 (22.8–28.3) | 26 (23.9–29.4) | 0.098d |
| Right side affecteda | 97 (54.4) | 44 (53.7) | 53 (51.5) | 0.770c |
| Cigarette smokera | 42 (22.7) | 22 (26.8) | 20 (19.4) | 0.289c |
| Diabetesa | 11 (5.9) | 5 (6.1) | 6 (5.8) | 1.000c |
| Follow-up (months)b | 46 (31–62) | 49 (33–64) | 43 (29–60) | 0.155d |
| Cast immobilizationa | 179 (96.8) | 82 (100) | 97 (94–102) | 0.035c |
| Immobilization (weeks)b | 6 (6–8) | 6 (6–8) | 6 (6–8) | 0.412d |
P values <0.05 are considered statistically significant
Data are shown as a numbers with the percentage between brackets or as b median with the P25–P75 given between brackets
Data are analyzed using a c Chi Square analysis or d Mann–Whitney U test
Fig. 1Fracture type distribution as classified according to AO-Weber; a conservatively treated patients, b operatively treated patients
Fig. 2Fracture type distribution as classified according to Lauge-Hansen; a conservatively treated patients, b operatively treated patients
Radiographic findings
| Variable | Total | Conservative | Operative |
|
|---|---|---|---|---|
| Malleoli involveda | ||||
| Unimalleolar | 145 (78.4) | 76 (92.7) | 69 (67.0) | <0.001c |
| Bimalleolar | 23 (12.4) | 4 (4.9) | 19 (18.4) | |
| Trimalleolar | 17 (9.2) | 2 (2.4) | 15 (14.6) | |
| Luxationa | 12 (6.5) | 0 (0) | 12 (11.7) | <0.001c |
| Pre-operative | ||||
| MCS (mm)b | 2.85 (2.26–3.90) | 2.53 (2.19–3.06) | 3.66 (2.32–5.93) | <0.001d |
| Fibular displacement (mm)b | 1.08 (0.00–1.83) | 0.00 (0.00–1.48) | 1.39 (0.66–2.38) | <0.001d |
| Post-operative | ||||
| MCS (mm)b | 2.58 (2.16–3.12) | N.A. | 2.58 (2.16–3.12) | N.A. |
| Fibular displacement (mm)b | 0.00 (0.00–0.43) | N.A. | 0.00 (0.00–0.43) | |
P values <0.05 are considered statistically significant
MCS Medial Clear Space, N.A. not applicable
Data are shown as a numbers with the percentage between brackets or as b median with the P25–P75 given between brackets
Data are analyzed using a c Chi Square analysis or d Mann–Whitney U test
Multivariable analysis of factors influencing outcome in patients treated A conservatively or B operatively
| Variable | OMAS | AOFAS | VAS | |||
|---|---|---|---|---|---|---|
| Beta (95% CI) |
| Beta (95% CI) |
| Beta (95%CI) |
| |
| A Conservatively treated patients | ||||||
| Follow-up duration | 0.021 (−0.184; 0.220) | 0.859 | 0.112 (−0.117; 0.333) | 0.341 | 0.114 (−0.012; 0.034) | 0.344 |
| Age | −0.288 (−0.621; −0.044) |
| −0.152 (−0.518; 0.123) | 0.224 | −0.124 (−0.049; 0.016) | 0.327 |
| Gender | 0.072 (−6.562; 11.257) | 0.600 | −0.060 (−12.107; 7.713) | 0.443 | 0.0522 (−0.814; 1.193) | 0.708 |
| Affected side | −0.198 (−13.876; 1.108) | 0.094 | −0.241 (−17.109; −0.442) |
| −0.170 (−1.460; 0.228) | 0.150 |
| Number of malleoli | −0.206 (−18.053; 0.941) | 0.077 | −0.149 (−17.693; 3.677) | 0.195 | −0.113 (−1.616; 0.562) | 0.338 |
| Pre-MCS | 0.098 (−4.034; 8.878) | 0.456 | −0.019 (−7.007; 6.662) | 0.886 | 0.020 (−0.672; 0.783) | 0.879 |
| Pre-Mueller | −0.209 (−8.129; 0.662) | 0.095 | −0.212 (−9.160; 0.618) | 0.086 | −0.276 (−1.046; −0.055) |
|
| BMI | −0.179 (−1.222; 0.160) | 0.130 | −0.360 (−1.973; −0.436) |
| −0.215 (−0.149; 0.006) | 0.072 |
| Smoking | −0.217 (−16.314; 0.567) | 0.067 | −0.170 (−16.351; 2.425) | 0.143 | −0.086 (−1.302; 0.600) | 0.464 |
| Diabetes | 0.029 (−14.646; 18.760) | 0.807 | 0.076 (−12.458; 24.700) | 0.513 | −0.126 (−2.888; 0.875) | 0.289 |
| Immobilization duration | −0.371 (−4.476; -0.849) |
| −0.076 (−2.636; 1.398) | 0.542 | −0.247 (−0.403; 0.006) | 0.057 |
| B Operatively treated patients | ||||||
| Follow-up duration | −0.089 (−0.324; 0.064) | 0.513 | −0.089 (−0.341; 0.173) | 0.517 | −0.005 (−0.022; 0.021) | 0.972 |
| Age | −0.073 (−0.436; 0.252) | 0.595 | −0.058 (−0.438; 0.287) | 0.679 | −0.096 (−0.041; 0.020) | 0.489 |
| Gender | 0.065 (−6.895; 11.573) | 0.614 | 0.164 (−3.601; 15.872) | 0.212 | 0.056 (−0.639; 0.990) | 0.668 |
| Affected side | −0.141 (−13.503; 3.706) | 0.259 | −0.105 (−12.881; 5.264) | 0.404 | −0.145 (−1.202; 0.317) | 0.249 |
| Luxation | −0.087 (−52.265; 26.028) | 0.505 | 0.086 (−27.743; 54.808) | 0.515 | 0.184 (−1.006; 5.903) | 0.162 |
| Number of malleoli | −0.191 (−13.527; 1.593) | 0.120 | −0.229 (−15.361; 0.447) | 0.064 | −0.190 (−1.189; 0.145) | 0.123 |
| Pre-MCS | 0.057 (−1.384; 2.091) | 0.685 | 0.091 (−1.248; 2.415) | 0.526 | 0.032 (−0.136; 0.171) | 0.822 |
| Pre-Mueller | 0.141 (−1.612; 5.188) | 0.297 | −0.002 (−3.606; 3.564) | 0.991 | −0.02 (−0.322; 0.278) | 0.883 |
| Post-MCS | 0.048 (−3.796; 5.659) | 0.695 | −0.08 (−6.583; 3.385) | 0.524 | −0.101 (−0.588; 0.247) | 0.417 |
| Post-Mueller | −0.158 (−15.490; 3.534) | 0.214 | 0.066 (−7.412; 12.647) | 0.604 | −0.021 (−0.908; 0.771) | 0.871 |
| BMI | −0.209 (−1.921; 0.307) | 0.153 | −0.198 (−1.971; 0.379) | 0.181 | −0.187 (−0.162; 0.035) | 0.202 |
| Smoking | −0.039 (−12.991; 9.554) | 0.762 | 0.091 (−7.645; 16.127) | 0.478 | 0.125 (−0.505; 1.485) | 0.329 |
| Diabetes | 0.042 (−16.665; 23.186) | 0.745 | 0.129 (−10.613; 31.406) | 0.326 | 0.133 (−0.857; 2.660) | 0.309 |
| Immobilization duration | −0.368 (−4.063; −0.515) |
| −0.375 (−4.307; −0.565) |
| −0.286 (−0.313; 0.001) | 0.051 |
BMI Body mass index, AOFAS American Orthopaedic Foot Ankle Society ankle-hindfoot score, OMAS Olerud–Molander Ankle Score, VAS Visual Analog Scale, MCS Medial Clear Space, pre-Mueller dislocation of the distal fibular fragment pre-operative; post-Mueller dislocation of the distal fibular fragment post-operative
P-values printed in bold show statistical significant associations